Cargando…

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer

This review details the clinical utility of Immunoscore, measuring the immune response to cancer within the tumor microenvironment, in bladder cancer. Immunoscore was recently introduced into ESMO Clinical Practice Guidelines for gastrointestinal cancer and into the WHO classification of the Digesti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nassif, Elise F., Thibault, Constance, Oudard, Stéphane, Galon, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Author’s View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899086/ https://www.ncbi.nlm.nih.gov/pubmed/33659099 http://dx.doi.org/10.1080/2162402X.2021.1888488

Ejemplares similares

Usefulness and robustness of Immunoscore for personalized management of cancer patients
por: Marliot, Florence, et al.
Publicado: (2020)

The consensus immunoscore: toward a new classification of colorectal cancer
por: Lanzi, Anastasia, et al.
Publicado: (2020)

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients
por: Baldin, Pamela, et al.
Publicado: (2020)

The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions
por: Pagès, Franck, et al.
Publicado: (2020)

The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisions
por: Lanzi, Anastasia, et al.
Publicado: (2020)

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study
por: Ascierto, Paolo A., et al.
Publicado: (2020)

The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival
por: Nassif, Elise F., et al.
Publicado: (2021)

Turning tolerogenic into immunogenic ileal cell death through ileal microbiota: the key to unlock the mystery of colon cancer immunoscore?
por: Roberti, Maria Paula, et al.
Publicado: (2020)

The immune landscape of human tumors: Implications for cancer immunotherapy
por: Bindea, Gabriela, et al.
Publicado: (2014)

Multiverse of immune microenvironment in metastatic colorectal cancer
por: Van den Eynde, Marc, et al.
Publicado: (2020)

Tumor spread or siege immunity: dissemination to distant metastasis or not
por: Bindea, Gabriela, et al.
Publicado: (2021)

License to kill: microsatellite instability and immune contexture
por: Maby, Pauline, et al.
Publicado: (2021)

Metastasis immune-based scores predict patient survival
por: Mlecnik, Bernhard, et al.
Publicado: (2020)

Evasion before invasion: Pre-cancer immunosurveillance
por: Angelova, Mihaela, et al.
Publicado: (2021)

Expand to shield: IL-15 and in situ lymphocytic proliferation
por: Bindea, Gabriela, et al.
Publicado: (2021)

Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2014)

Trial watch: Immunostimulatory cytokines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2014)

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
por: Hijazi, Assia, et al.
Publicado: (2023)

Blocking IL-10 enhances bacillus Calmette-Guérin induced T helper Type 1 immune responses and anti-bladder cancer immunity
por: Luo, Yi
Publicado: (2012)

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
por: El Sissy, Carine, et al.
Publicado: (2021)

Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015)

Personalizing immunotherapy: Balancing predictability and precision
por: Agur, Zvia, et al.
Publicado: (2012)

Trial Watch: Toll-like receptor agonists in oncological indications
por: Aranda, Fernando, et al.
Publicado: (2014)

Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
por: Jinesh G., Goodwin, et al.
Publicado: (2012)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment
por: Said, Neveen, et al.
Publicado: (2012)

Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer
por: Sandin, Linda C, et al.
Publicado: (2014)

Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivo
por: Gargiulo, Ernesto, et al.
Publicado: (2022)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

The colorectal cancer immune paradox revisited
por: Angelova, Mihaela, et al.
Publicado: (2015)

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
por: Ascierto, Paolo A, et al.
Publicado: (2013)

The peripheral immune response and lung cancer prognosis
por: Showe, Michael K., et al.
Publicado: (2012)

PD-L1 immune suppression in cancer: Tumor cells or host cells?
por: Kleinovink, Jan Willem, et al.
Publicado: (2017)

Immune cells in pancreatic cancer: Joining the dark side
por: Zhang, Yaqing, et al.
Publicado: (2014)

"Flagellated" cancer cells propel anti-tumor immunity
por: Garaude, Johan, et al.
Publicado: (2012)

Comparison of Immune Response Assessment in Colon Cancer by Immunoscore (Automated Digital Pathology) and Pathologist Visual Scoring
por: Boquet, Isabelle, et al.
Publicado: (2022)

Hormesis in cancer immunology: Does the quantity of an immune reactant matter?
por: Pearce, Oliver MT, et al.
Publicado: (2014)

Engineering Grp170-based immune modulators for cancer immunotherapy
por: Yu, Xiaofei, et al.
Publicado: (2013)

The perioperative immune/inflammatory insult in cancer surgery: Time for intervention?
por: Roxburgh, Campbell S, et al.
Publicado: (2013)

Opposing effects of androgen ablation on immune function in prostate cancer
por: Tang, Shuai, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_upl216e5urjvb6m1j3lhg9vpqa